Diagnostic Testing for Respiratory Conditions {#Sec1}
=============================================

Pulmonary Function Testing (PFT) {#Sec2}
--------------------------------

Definition of lung volumes and capacities:4 volumes: IRV inspiratory reserve volumeTV tidal volumeERV expiratory reserve volumeRV residual volume:  Volume at maximal expirationCapacities are sums of volumesTLC total lung capacity (all four volumes) -- volume at maximal inspirationIC inspiratory capacity: (TV + IRV)FRC functional residual capacity (RV + ERV) -- resting volume at the end of normal expirationVC vital capacity: (RV + ERV + TV = TLC -- RV)

SpirometryProvides objective measurements that can be tracked over timeForced maneuver breathing from full inspiration (TLC) to RV capturing VCDisplays volume exhaled and flow ratesFVC---volume after full-forced exhalationFEV1---volume exhaled during first secFEV1/FVC ratio---low with obstructionFEF 25--75---average flows between 25% and 75% of the maneuverInterpreted to show obstruction (low flow), restriction (low volume), or mixed process (Fig. [20.1](#Fig1){ref-type="fig"})Obstruction: N ↓ FVC, ↓ FEV1, ↓ FEV1/FVC, ↓ FEF 25--75Restriction: ↓ FVC, ↓ FEV1, N FEV1/FVC, ↓ FEF 25--75Consider further testing if spirometry is normal, but positive for asthma-type symptoms:Measurement of spirometry pre and post bronchodilator can be used to evaluate for airway reactivityIncrease in FEV1 after bronchodilator (significant if \> 12% change)Bronchial challenge testing to measure bronchoconstrictionInhalation challenge or exercise challenge (e.g., methacholine, histamine, cold air, exercise)Fig. 20.1Flow volume loop configurations in normal and different pulmonary disorders. Loop above line is expiratory loop; loop below line is inspiratory. (**a**) Normal; (**b**) early small airway obstruction; (**c**) chronic obstructive disease; (**d**) variable extrathoracic large airway obstruction, e.g., vocal cord pathologies; (**e**) restrictive diseases

Lung VolumesUseful in evaluation of restrictive lung disease (low TLC)Measurement of RV impossible with spirometryEvaluated byPlethysmography (body box)---most accurateNitrogen washout, underestimates volume, if obstructive process presentDiffusion capacity measured with use of carbon monoxide gasMeasure of gas transfer across alveolar-capillary barrierMay be decreased in interstitial lung disease, after lung resection

Pulse Oximetry {#Sec5}
--------------

Noninvasive, continuous, and rapid measure of peripheral oxygen saturation (SpO2)SpO2 estimates percentage of hemoglobin bound by oxygenOxyhemoglobin curve dissociation curve = relation between partial pressure oxygen (pO2) and hemoglobin saturation (Fig. [20.2](#Fig2){ref-type="fig"} )In hypoxia, pO2 is on steep part of curve = small pO2 changes, but large SpO2 changesAcidosis, hyperthermia, increase in CO2 shifts curve to the right (lower SpO2 for same pO2)Limitations of pulse oximetryInaccurate readings with poor perfusion, severe anemia, motion artifact, shifts in oxyhemoglobin dissociation curve (e.g., acidosis), deep pigmentation of the skin, dark nail polishPresence of methemoglobinemia and carboxyhemoglobin not recognized by most oximeters and may overestimate SpO2Co-oximeter used to measure effect of dyshemoglobinemias Fig. 20.2Oxyhemoglobin saturation curve

Blood Gas Analysis {#Sec6}
------------------

Gold standard for blood gas analysis is an arterial blood gas (ABG) sample.ABG interpretation (see Table [20.1](#Tab1){ref-type="table"} for ABG values associated with various conditions)Upper airway obstructionEarly increase in pCO2 and proportionate decrease in pO2. Initially responds well to supplemental oxygenIntrapulmonary airway obstructionMild: Decrease in pCO2, normal to decreased pO2Moderate: Normal pCO2, decrease pO2 moving toward failureSevere: Increase pCO2 and decrease pO2Supplemental oxygen will support patient, but imperative to monitor carbon dioxide as wellR-L shuntEarly decrease in pO2Normal or low pCO2, high pCO2 with development of fatigueTesting with 100% oxygen helps to define: Response to supplemental oxygen is fair to poor, depending on degree of shunt **Limitations of capillary blood gases (CBG)** Arterialized CBG obtained by warming of a well-perfused heel or earlobeCBG is more easily attainable than arterial sampleValues are comparable to arterial pH and pCO2, but pO2 measurement in CBG is less reliableInaccuracy of blood gas measurements increased if sample processing is delayed, white blood cell (WBC) metabolism continues to consume oxygen and results in acidosis Table 20.1Arterial blood gases: values associated with various conditionsAcid-base abnormalitypHpCO2HCO3Possible causesNormal range7.35--7.4535--4521--27***Respiratory acidosis***Hypoventilation, neuromuscular disorders, severe asthma exacerbation, airway obstruction, intrinsic lung disease, pneumoniaAcute↓↑NCompensatedN↓↑↑***Respiratory alkalosis***Pain, hyperventilation, pulmonary embolism, high altitudeAcute↑↓NCompensatedN↑↓↓***Metabolic acidosis***Methanol, diabetic ketoacidosis, inborn error of metabolism, lactic acidosis, salicylates, diarrhea, shockAcute↓N↓CompensatedN↓↓↓***Metabolic alkalosis***Vomiting, diuretics, primary aldosteronismAcute↑N↑CompensatedN↑↑↑*N* Normal

Chest Imaging {#Sec7}
-------------

Suggested modalities for various issues**Plain chest radiograph (CXR)**Upright views: Atelectasis, pneumonia, pneumothoraxInspiratory and expiratory or bilateral decubitus views for suspected foreign body may be able to see asymmetric hyperinflation inside with foreign body due to check valve effectMost foreign bodies not seen, as they are radiolucentIn bilateral decubitus views, dependent side should have lower volume (like expiratory view) than upright sideDecubitus views: Pleural fluid, pneumothorax**Fluoroscopy:** Tracheomalacia, diaphragmatic movement**Upper gastrointestinal (UGI) series:** Vascular ring, tracheoesophageal fistula**Video swallow study:** Aspiration**Ultrasound:** Pleural effusion, complicated pneumonia, diaphragm**Computed tomography (CT) scan:**Best at providing images of lung anatomy, airway tree, parenchyma, and vascular structuresHigh resolution: Better to evaluate parenchyma like in bronchiectasis or interstitial lung diseaseContrast: Used to evaluate for lymphadenopathy, masses, vascular abnormalities, arteriovenous malformations, pulmonary embolism**Positron emission tomography (PET) scan:** Anterior , middle mediastinal masses, lymphoma**Ventilation-perfusion scan:** Pulmonary embolism**Magnetic resonance imaging (MRI):** Vascular lesions, mediastinal and chest wall masses

General Signs and Symptoms {#Sec8}
==========================

Stridor/Wheezing {#Sec9}
----------------

**Background** WheezingA musical, high-pitched whistling sound produced by airflow turbulenceOne of the most common symptoms in asthma (see amplified discussion)StridorHigh-pitched, harsh sound often audible without the stethoscopeResults from rapid, turbulent airflow through a partially obstructed airwayInspiratory versus expiratory*In*spiratory---*Ex*trathoracic swelling or obstruction will lead to airway collapse on inspiration. Example: Laryngomalacia*Ex*piratory---*In*trathoracic swelling or obstruction will lead to airway collapse on expiration. Example: Tracheomalacia*Biphasic stridor*---Indicates fixed airflow obstruction, subglottic space obstruction

Differential Diagnosis of Acute Stridor {#Sec10}
---------------------------------------

**Croup or laryngotracheobronchitis** (see amplified discussion)**Foreign body aspiration** (see amplified discussion)Most common between 1 and 3 years of ageSudden onset with cough, stridor, or wheezing**Bacterial tracheitis** (see amplified discussion)**Spasmodic croup or acute spasmodic laryngitis** Children 6 months to 5 yearsNo viral etiology but symptoms similar to viral croupMay be triggered by gastrointestinal (GI) reflux**Retropharyngeal abscess** Preschool age groupAbrupt onset of high fevers, difficulty swallowing, refusal to feed, sore throat, hyperextension of the neck or torticollis, and respiratory distress**Peritonsillar abscess** Preadolescents and adolescentsSevere throat pain, trismus, muffled voice, trouble swallowing or speaking**Allergic reaction or anaphylaxis** Associated with itchiness or hivesHistory of allergy

Differential Diagnosis of Chronic Stridor {#Sec11}
-----------------------------------------

***Laryngomalacia*** Most common cause of stridor in infantsAccounts for up to 75% of all causes of stridor**Clinical presentation** Onset shortly after birth, minimal respiratory distress, positional effects, and marked reduction of noise when infant is at restMay present with apnea and feeding difficultiesStridor improves in prone position with head elevated and worsens in supine positionAssociated with normal voice quality and pitch**Diagnosis** Diagnosis cannot be established on the basis of standard radiograph of the neckFlexible laryngoscopy can confirm the diagnosis but may miss tracheal abnormalities that can be identified with bronchoscopyIf moderate to severe obstruction, difficulty with feeding and breathing, or unable to gain weight, flexible or rigid bronchoscopy to rule out other associated airway anomalies**Management** Usually benign and self-limiting and improves as the child reaches 1--2 years of ageCareful observation and growth monitoring for most patientsSurgical correction may be considered in severe casesResolution of symptoms for most patients without therapy in early childhood ***Choanal Atresia*** 50% associated with congenital anomalies (i.e., CHARGE association, mnemonic for ***C***oloboma, ***H***eart defects, ***C***hoanal atresia, ***R***etarded growth and development, ***G***enital abnormalities, and ***E***ar anomalies)Bilateral---medical emergency during neonatal period, intermittent respiratory distress relieved by cryingUnilateral---chronic mucoid nasal discharge on affected side in older infants/young childrenDiagnosis: Inability to pass a 6F catheter into oropharynx through noseManagement: Surgical ***Vocal Cord Paralysis (VCP)*** Second most common cause of stridor in infantsMay result from local traumaLeft side VCP may result from trauma to the recurrent laryngeal nerve at birth or surgical traumaUnilateral---congenital or secondary to birth or surgical trauma such as cardiothoracic surgeryBilateral---associated with central nervous system abnormalities such as Arnold-Chiari malformation, tumors, or increased intracranial pressure**Clinical presentation** Unilateral VCP ---hoarse voice, weak cry, and biphasic stridor that is louder when awake. Improves when lying with the affected side downBilateral VCP ---high-pitched biphasic stridor that may progress to severe respiratory distress. Rarely associated with abnormal vocalizationBilateral VCP is associated with increased risk of recurrent aspirationVCP may be an early sign of brain stem or spinal cord compression**Imaging** MRI of the upper spinal cord and brain stem may be required in evaluating patients with unexplained bilateral VCP**Management** Presence of aspiration and the degree of airway obstruction---primary indicators of need for therapy in patients with VCPContinuous positive pressure may provide temporary relief of symptoms of VCPDecompression surgery is required to relieve VCP secondary to Arnold-Chiari malformationTraumatic VCP should improve in 6 months and, if not, unlikely to improve thereafter***Laryngeal Web***Strong association with velocardiofacial syndrome (chromosome 22q11.2 deletion)Posterior glottic webs are acquired from prolonged intubationLaryngeal webs may be associated with anterior subglottic stenosisWeak cry and biphasic stridor**Management** Surgery can be curative if significant obstruction occursEmergency tracheostomy is required to relieve obstruction caused by a complete laryngeal web ***Subglottic Stenosis (SGS)***SGS may be congenital (rare and usually associated with other genetic syndromes or conditions) or post-traumatic (due to airway instrumentation or more commonly, intubation)Even brief periods of intubation may result in chronic SGSAirway inflammation secondary to trauma may lead to acquired SGSThe cricoid cartilage , being a complete ring, is predisposed to traumatic injury and stenosis**Clinical presentation** History of recurrent croup, a protracted croup illness, previous intubation or airway instrumentationBiphasic stridorRetractions, flaring , high-pitched stridor, and diminished air entry are associated with significant SGSHypoxemia or carbon dioxide retention in a child with SGS indicates a severe obstruction leading to marked hypoventilation**Diagnosis** Spirometry will demonstrate flattened inspiratory loopsEndoscopy will demonstrate narrowing of the subglottic spaceNo correlation between the radiographic appearance of SGS and actual degree of narrowing on direct visualization**Management** If subglottic space only allows an endotracheal tube (ETT) two sizes smaller than expected, consider surgical interventionA cricoid split procedure may provide an alternative to tracheostomy in infants with SGS ***Subglottic Hemangioma*** Rare cause of upper airway obstruction in children**Clinical presentation** Considered in the differential diagnosis of chronic upper airway obstruction50% accompanied by cutaneous hemangiomas of head and neckInspiratory or biphasic stridor that worsens as hemangiomas enlargeLikely to shrink with age and usually do not require therapy**Diagnosis** Upper airway endoscopy---asymmetric compressible bluish mass in the subglottic space**Management** Treatment options include steroids, laser, intralesional steroid injections, and open surgical excisionPropranolol from months to years by center with expertiseTracheostomy in severe obstruction ***Laryngotracheoesophageal Cleft*** Associated with tracheoesophageal fistulasRare cause of recurrent aspirationNeonates with severe clefts may present with respiratory distressDefect involves the anterior wall of the upper esophagus and the posterior aspect of the larynx, with the defect lying in the interarytenoid space**Clinical presentation** Recurrent aspiration and cyanosis with feeding are the most common clinical presentation**Diagnosis** Direct laryngoscopy rather than transnasal fiber-optic endoscopy is the diagnostic method of choice**Management** Type 1---Conservative management with swallow therapy and thickening of feedingsTypes 2--4---Surgical intervention and swallow therapy ***Macroglossia*** Macroglossia predisposes patients to obstructive sleep apnea (OSA)Lateral-view radiograph to evaluate anatomic relationship between tongue and airwayProne positioning may help in the acute management of airway obstruction due to macroglossiaAirway obstruction may improve with age

Cough {#Sec12}
-----

**Background** Cough sensors present in upper and lower airway mucosa, paranasal sinuses, upper GI tract, external auditory canalNocturnal cough is rare in normal children**Clinical presentation** Differential is wide , so narrow possible diagnoses with history and physical:Age, exposures, family history of asthma, allergies, or lung diseaseType of coughWet, dry, frequency, diurnal, nocturnal, length of cough, seasonality, quality, presence of hemoptysisSputum production (bronchitis, cystic fibrosis \[CF\], primary ciliary dyskinesia \[PCD\], bronchiectasis)QualityBrassy (tracheal irritation, tracheomalacia)Barky (croup)Honking (habit cough)Staccato (chlamydia, mycoplasma)Paroxysmal/whoop (pertussis, CF, foreign body)Association to feedings and exercise (aspiration, exercise-induced asthma)Associated with persistent rhinitis: allergies, PCDRecurrent pneumonia ---immunodeficiencyIf not present during sleep in school age/adolescent, consider habit coughNighttime cough: asthma, sinusitisResponse to medicationsUseful physical findings: stridor, wheezing, clubbing, poor growth, eczema, tachypnea, focal auscultatory findings, chest wall abnormalitiesAcute cough usually resolves in 1--3 weeks in 90% of childrenSubacute cough lasts 3--8 weeks and chronic cough \> 8 weeks**Differential diagnosis**Considerations by length of cough:*Acute:* Allergies, foreign body, upper respiratory tract infections*Subacute:* Postinfectious cough, viral, pertussis*Chronic cough:*All age groups: Gastroesophageal reflux (GER), exposures (tobacco smoke, pollution)Other considerations by age:Infants: Aspiration, congenital airway abnormalities, CF (even if neonatal screen is normal), neonatal infection, chlamydia, congenital heart disease (CHD)Toddlers/preschoolers : Upper respiratory infection (URI), asthma, foreign body, postinfectious cough, pertussis, mycoplasma, immunodeficiencies, bronchiectasis, CFSchool age/adolescents : Asthma, upper airway cough syndrome, smoking, tuberculosis (TB), bronchiectasis, habit cough**Evaluation of chronic cough**Look for clues and pointers and tailor evaluation according to most likely diagnoses:CXRPulmonary function (spirometry)Sputum cultureAllergy testingSwallow studySweat testImmune function testing, including complete blood count (CBC) with differential, immunoglobulinsPurified protein derivative (PPD) testConsider chest CT if cough is productiveEchocardiogramRefer to specialists for further evaluations, e.g., laryngoscopy, bronchoscopy, echocardiogram**Management** Recurrent respiratory tract infections/postinfectious cough: Symptomatic therapyUpper airway cough syndrome: Antihistamines, nasal steroidsDry cough/wheezing : Trial bronchodilators with environmental modifications. If positive response, consider trial with inhaled corticosteroids (ICS)GER: AntacidsPsychogenic cough : Behavioral modificationsFurther management based on diagnostic findings: Refer to specialists for complicated diagnoses

Tachypnea {#Sec13}
---------

Definition by age (breaths/min):Birth to 30 days \> 602 to 12 months \> 501 to 5 years old \> 40Older than 5 \> 20Subtract 10 if the child is febrile

Exercise Intolerance {#Sec14}
--------------------

The reference standard is the maximal oxygen consumption (VO2 max)Pulmonary conditionsMost common: Exercise-induced asthma (EIA) and CFLess common: Interstitial lung diseasesCardiovascular conditionsCongestive heart failure and CHD (most common CHD = tetralogy of Fallot)Muscular conditions, especially those associated with neuromuscular weaknessDuchenne muscular dystrophyHematologic disordersIron deficiency anemiaSickle cell diseaseVocal cord dysfunctionParadoxical motion of vocal cordsMore common in adolescent femalesMay mimic EIA---Need to consider if not responding to EIA treatmentSedentariness---Leads to deconditioning, muscle weakness, and obesity

Respiratory Failure {#Sec15}
-------------------

Type 1 respiratory failure characterized by low blood oxygen levels (hypoxemia, low pO2, normal or decreased pCO2, and alveolar-arterial oxygen gradient (pA-aO2) is increased)Causes: V/Q mismatch, decreased minute volume, diffusion impairment or shuntType 2 respiratory failure affects both oxygen and carbon dioxide levelsLow pO2, high pCO2, normal pA-aO2Causes: Reduced breathing effort, increased airways resistance, neuromuscular diseaseTreating the underlying cause is paramount. In severe cases, intubation and mechanical ventilation are requiredIf related to respiratory depression is related to narcotics, reversal can be of benefit

Apnea {#Sec16}
-----

Defined by reduced or cessation in respiratory airflow **Three main types** ***Central*** Cessation of airflow secondary to reduction or lack of excitatory signals from central nervous system (brain stem) to respiratory musclesNo chest wall effortProlonged episodes (\> 20 s) are more clinically significant and usually associated with cyanosis and /or bradycardiaShorter episodes can be seen in periodic breathing, which is common in premature infants and decreases with age/maturation***Obstructive*** Airway (usually upper airway) obstruction/collapse leading to partial or complete obstruction of airflow in spite of chest wall effort***Mixed*** Combination of both central and obstructive componentsUsually central component followed by obstructive**Differential diagnosis of central apnea** Neonates/infants:Can present with central or mixed apneaMost common cause: Apnea of prematurity or apnea of infancyAssociated with immature respiratory centers, laryngeal reflex, and, when mixed, underdeveloped upper airway musculatureUsually resolves by 48--53 weeks postconceptional ageCan be treated with respiratory stimulants (e.g., caffeine) or continuous positive airway pressure (CPAP)Further evaluation warranted in younger infants (\< 2 months) and severe presentations requiring resuscitationOther causes of apnea during infancy usually more severe and include:Infection (e.g., sepsis, pneumonia, meningitis, pertussis, bronchiolitis, botulism)Head trauma, intraventricular hemorrhage, seizure, medicationsGER, necrotizing enterocolitisMetabolic derangements such as hypoglycemia and acidosis, inborn errors of metabolismHyper- or hypothermiaHeart failureAnemiaCongenital central hypoventilation syndromeOlder childrenCauses: Cerebral hemorrhage or infarction, brain tumor, seizures, hypoxic injury, spinal cord injury, drugs, medications**Evaluation** Guided by history (see amplified discussion for ALTE/BRUE)If severe presentation , young infant or older child, consider:CBC, serum glucose, electrolytesSepsis workupElectrocardiogram (ECG)Neuroimaging, electroencephalogram if clinically indicatedConsult pertinent specialistsOSA (see amplified discussion for OSA)

Cyanosis {#Sec17}
--------

**Background** Bluish tint of the skin, either centrally or peripherally, related to respiratory causes, central nervous system causes, or hematologic causesPulmonary causes are a result of poor oxygen deliveryCardiac causes include CHD and heart failureHematologic causes include methemoglobinemia and polycythemiaCan be caused by high altitude and hypothermia**Evaluation** Assessment of respiratory status---wheezing, distressCardiac assessment to include echo, and if concern for intrapulmonary shunt, consider contrast (bubble) echoABGMethemoglobin assessment

Chronic Hypoxia {#Sec18}
---------------

**Causes** Pulmonary venous desaturationLung disease with diffusion impairment (interstitial lung disease)Intrapulmonary right-to-left shunting (pulmonary arteriovenous malformations)Extrapulmonary/intracardiac right-to-left shuntingCyanotic CHD (tetralogy of Fallot, pulmonary atresia)Pulmonary hypertension can present with intracardiac right-to-left shuntingHemoglobin disorders with decreased oxygen affinityMethemoglobinemia (see expanded discussion)**Diagnosis** Hyperoxia testGive 100% oxygen and obtain a preductal blood gas (i.e., right upper extremity)Normal PaO2 \> 500 mmHgPulmonary disease PaO2 \> 150 mmHg, but \< 500 mmHgRight-to-left shunting PaO2 \< 150 mm HgCXR to evaluate for pulmonary pathologyCBC---If chronic, will show polycythemia

Methemoglobinemia {#Sec19}
-----------------

**Background** Methemoglobin (MetHb) cannot carry oxygen to tissuesMethemoglobin occurs with oxidation of ferrous (Fe2+) to ferric (Fe3+) hemoglobinMethemoglobinemia can be acquired or inheritedAcquiredMost common after exposure to exogenous oxidizing agent like nitritesIntestinal bacteria can convert nitrates in well water and pureed leafy vegetables to nitritesDehydrationInheritedDeficiency cytochrome-b5 reductaseHemoglobin M disease**Clinical Presentation** Presents as cyanosis with MetHb levels \> 15%Cyanosis with normal pulse oximetry, no respiratory or cardiac findings on physical exam**Evaluation** Pulse oximetry---May be normal, but does not increase with use of oxygenBlood gas---Chocolate-colored bloodCo-oximetry**Management** OxygenSevere cases: Methylene blue , N-acetylcysteine, exchange transfusion

Clubbing of Digits or Hypertrophic Pulmonary Osteodystrophy {#Sec20}
-----------------------------------------------------------

**Causes** The most common cause is cyanotic heart diseaseThe most common pulmonary causes are CF and bronchiectasis (usually more advanced disease)Biliary cirrhosisInfective endocarditisNormal variant as a familial trait**Diagnosis** Obliteration of the angle between the proximal nail and soft tissue of the digit (Schamroth sign)Normal anatomy shows a diamond-shaped space when placing the distal phalangeal joints in mirrorlike fashion

Hemoptysis {#Sec21}
----------

**Background** Hemoptysis (coughing blood) is uncommon but can be a serious manifestation of pulmonary disease in childrenPulmonary vasculature composed of two-pressure system:Bleeding from low-pressure pulmonary vessels (e.g., diffuse hemorrhage) leads to small-volume hemoptysis, while bleeding from systemic pressure bronchial vessels (e.g., bronchiectasis) tends to be profuse**Clinical presentation** Differentiating from hematemesis (vomiting blood) and epistaxis (nasal bleeding) can be trickyMost common reason for symptom usually not true hemoptysis but bleeding from upper airway (e.g., nasal bleeding)Diffuse hemorrhage is frequently slow and may present only with anemia and fatigue**Differential Diagnosis** Most common etiology of true hemoptysis is inflammation or infectionMore commonUpper airway and GI bleedingInfection such as bronchitis, pneumonia, lung abscess, TB, fungal infectionsForeign bodyCystic fibrosis, bronchiectasisLess commonAirway traumaTracheostomyCardiac (CHD, pulmonary hypertension, pulmonary embolism)RareAirway tumor (e.g., carcinoid)Arteriovenous fistulaBleeding disorderIdiopathic pulmonary hemosiderosisPulmonary renal syndromes (usually in older children)Granulomatosis with polyangiitis, Goodpasture syndrome, systemic lupus erythematosus, microscopic polyangiitis, Henoch-Schönlein purpuraFactitious hemoptysis**Evaluation** History and physical exam not usually helpful; other guided studies frequently useful in the investigationImaging including CXR or chest CT with contrast to localize lesion or find evidence of pulmonary hemorrhageHelpful labs: CBC for anemia; erythrocyte sedimentation rate (ERS), kidney function, urinalysis for renal involvement or inflammatory diseaseBronchoscopy can identify area of active bleeding and should include upper airway evaluation. Bronchoalveolar lavage for evidence of infection or hemosiderin-laden macrophages (presence indicates previous bleeding)Echocardiogram for cardiac disease**Management** Massive blood loss requires acute resuscitation with volume, blood products, and supportive care with oxygen and mechanical ventilationEvaluation by subspecialists (ear/nose/throat (ENT), pulmonologist, gastroenterology, rheumatology), depending on suspected cause

Respiratory Conditions of the Upper Airway {#Sec22}
==========================================

See discussion on stridor for general considerations

Viral Croup (Laryngotracheobronchitis) {#Sec23}
--------------------------------------

**Background** Most common cause is parainfluenzaCauses subglottic narrowingCommon between 3 months and 3 yearsSpasmodic croup similar without viral prodrome or other identifiable causeCricoid cartilage has a complete ring and is the narrowest part of the airway in infantsEdema at this level will lead to further narrowing, increased airway resistance, and possible airway compromise**Clinical presentation** Barking or brassy coughURI with or without fever, which may be high (39--40 °C)Respiratory distress with retractions with hypoxia and hypercapnia in severe upper airway obstructionChild may prefer to sit or be held uprightMild---no stridor at restModerate---stridor at rest but no agitationSevere---stridor and agitationRecurrent croup: Consider underlying anatomic airway abnormality, GER, or atopy**Diagnosis** Clinical diagnosisIn typical cases , CXR is not requiredCXR findings---steeple sign on frontal view is a common finding but may be absent**Management** Reassurance, observation, and hydrationDexamethasone 0.6 mg/kg beneficial in mild croup (may decrease need for hospitalization)Oxygen and racemic epinephrine in moderate or severe casesRacemic epinephrine does not lead to rebound worsening of obstruction, but patient may worsen when drug effects subside. A 2-h observation is important. Worsening of obstruction is unlikely to occur if patient does well after 4 h.Racemic epinephrine should be used cautiously in patients with left ventricular outlet obstructionLow-density gas such as helium-oxygen (heliox) may be effective in children with severe croupTurbulent flow through large airways is density-dependent.By decreasing gas density, airflow resistance can be decreased.Admit for severe distress, hypoxia, and inability to feed/drink or if requiring 2 or more racemic epinephrine treatmentsEndotracheal intubation recommended before patient is restless and cyanoticEndotracheal intubation using an ETT one size smaller than predicted tube size (based on age and weight) is the preferred method of establishing an artificial airway in patients with viral croupIntubation more likely for bacterial tracheitis and epiglottitis and rare in croupIf intubation needed, consider measles or influenza A**Prognosis** Course of viral croup in infants younger than 1 year of age is prolongedSymptoms often improve during the day with recurrence of symptoms in the early hours of the morning

Epiglottitis {#Sec24}
------------

**Background** Most common pathogen *Haemophilus influenzae*Rare in children due to *H. influenzae* vaccination, which leads to individual and herd immunityMore common in the elderly and immune-compromised children than in the general populationUncommon pathogens that can cause epiglottitis: Herpes viruses and fungiPathology involves the epiglotis and other supraglottic structures, but the subglottic space and trachea are usually spared**Clinical presentation** Rapid onset of illness (hours) with high fever, sore throat, drooling with difficulty swallowing, and difficulty breathingPatient sitting up and leaning forward position to enhance airflowStridor is not a prominent featureRadiograph lateral neck view: Thumb sign**Management** Patients with acute epiglottitis should undergo endotracheal intubation to ensure an adequate airway until inflammation subsidesIn severe cases, avoid unnecessary studies until airway is securedA skilled provider needs to remain with a patient with epiglottitis until the airway is visualized and secured

Bacterial Tracheitis {#Sec25}
--------------------

**Background** Most common organisms are *Staphylococcus aureus*, *Moraxella catarrhalis,* and *Streptococcus*Mean age is 4 years (range 4 weeks to 13 years, typically about 2 years)**Clinical presentation** Brassy and barky cough, but the patient has high fever and appears very toxic with respiratory distress and stridorPatient may lay flat and does not have drooling or dysphagia associated with epiglottitisRapid progression and purulent secretions may mandate early endotracheal intubationDoes not respond to racemic epinephrine or corticosteroids**Diagnosis** CXR not needed but may show the classic findings of pseudomembrane detachment in the tracheaHigh fever, purulent airway secretions, absence of findings of epiglottitis**Management** Intubation, especially for younger patients; 50--60% do not require intubationHumidification and careful suctioning of the ETT are importantAntistaphylococcal treatment (i.e., nafcillin or vancomycin)Prognosis is goodComplications can include ARDS, toxic shock, septic shock, pulmonary edema, and subglottic stenosis

Respiratory Conditions of the Lower Airway and Parenchyma {#Sec26}
=========================================================

Congenital Airway and Pulmonary Malformations {#Sec27}
---------------------------------------------

**Pulmonary SequestrationBackground** *Extralobar:* More common in males; 65% in the left lung, covered by pleura, fed by systemic artery, and drained via systemic vein. May be associated with diaphragmatic hernia and colonic duplication*Intralobar:* Typical in the lower lobe, systemic arterial supply, variable venous drainage, and airway connections**Clinical presentation** Dullness on percussion, decreased breath sounds over the lesion, continuous murmur may be heard on the back, and crackles if infected**Evaluation** Fetal ultrasound or ultrasound following birth may detect pulmonary massCT scan with contrast confirms diagnosis**Management** Surgical removal because retained sequestrations have a small possibility of becoming malignantConsultations: Pulmonology and surgery **Bronchogenic CystBackground** Arise from abnormal budding of the tracheal diverticulumPatient may become symptomatic if the cyst enlarges or becomes infectedMay be asymptomatic and found incidentally**Clinical presentation** Fever, chest pain, and productive cough are the most common presenting symptomsDysphagia, if causing pressure on the surrounding structuresCXR can show the cyst, but CT or MRI demonstrates anatomy (usually medial mediastinum)**Management**Surgical removal **Vascular Ring/SlingBackground** Congenital anomalies of the large vessels (such as aortic arch)May involve airway and/or esophagusVariable severity and timing of presentation but, if significant, usually presents during infancy**Clinical presentation** May cause stridor or wheezing, cough, apnea, failure to thrive, and/or dysphagiaImaging:Echocardiogram, CT, and MRI help define anatomy. Can be associated with tracheomalacia secondary to airway compressionEsophagogram may indirectly diagnose by demonstrating compression of abnormal vessel upon esophagus**Management** Surgical intervention **Tracheal StenosisBackground** Narrowing of tracheal lumen frequently associated with complete tracheal ringsCan vary from short- to long-segment stenosisCondition is rare**Clinical presentation** Varies depending on degree of obstructionIf severe, presents during neonatal period or infancy with respiratory distress, cyanosis, stridor, cough, and dysphagia**Diagnosis** Direct visualization via rigid bronchoscopeCT scan could be used to reconstruct via "virtual bronchoscopy"Echocardiogram to evaluate associated CHD**Management** Surgical interventionRefer to pediatric ENT or airway surgical specialist

Congenital Pulmonary Adenomatoid Malformation {#Sec28}
---------------------------------------------

**Background** More prevalent in the left lower lobe5 subtypesMost are Type 1 (70%): Large (\> 5 mm) single or multiple cystsType 3 (10%): Microcystic , solid, and associated with other anomalies. Worse prognosis**Clinical presentation** Asymptomatic to respiratory distress depending on extent**Evaluation** Can be identified by prenatal ultrasoundCT scan is diagnostic**Management** Resection if respiratory distress, markedly symptomaticIf asymptomatic, can observe, but eventually most are surgically removedEven if asymptomatic, there is increased future risk for infections and small risk for malignancy

Congenital Lobar Emphysema {#Sec29}
--------------------------

**Background** Congenital bronchial obstruction leads to air trapping and distention of involved lungRarePrevalence: Left upper lobe \> right middle lobe/right lower lobe**Clinical presentation** Usual presentation in infancy with respiratory distress, tachypnea, hypoxemia**Diagnosis** CXRInitially may present in neonate with opacification due to fluidSubsequently, there is hyperinflation with shift to contralateral sideConfirmation with CT scan**Management** Surgical resection /lobectomy

Foreign Body (FB) Aspiration {#Sec30}
============================

**Background** Nuts, particularly peanuts, make up one-third of casesRound, globular FBs (hot dog, grapes, nuts, hard candies) are the most frequently found, causing a complete airway obstructionMost common in age \< 3 years**Clinical presentation** Initial event: Violent, paroxysmal coughing, choking, gagging, possible airway obstruction if the FB is largeAsymptomatic interval: FB becomes lodged, reflexes fatigue, immediate irritation subsides. This stage is most dangerous and accounts for delayed diagnosisIn this stage, FB might be missed, as physician is reassured by the absence of symptomsA positive history must never be ignored, and negative history can be misleadingCoughing or choking episode accompanied by wheezing is highly suggestive of FB in the airway.Must question about nuts, small toys, other small items58% lodge in the right bronchus**Diagnosis** CXR is negative in 10--30% of casesIf there is suspicion for FB , patient should undergo inspiratory and expiratory CXRs; in the uncooperative patient, consider doing bilateral decubitus filmsA lack of radiographic findings does not exclude an airway FB; many objects are organic and likely to be radiolucentPositive radiographic findings include hyperinflation, atelectasis, or infiltrateSoft tissue film of the neck can be of benefit to detect objects in the upper airwayPatients with tracheostomy are at a higher risk**Management** Ideal treatment is prompt removal with rigid bronchoscopyCan defer bronchoscopy until proper hydration and emptying of the stomach**Complications** Retained foreign body can lead to hemoptysis, lung abscess, and ultimately bronchiectasis

Pulmonary Hemosiderosis {#Sec31}
=======================

**Background** Repeated episodes of intra-alveolar bleeding that leads to abnormal accumulation of iron (hemosiderin) in the alveolar macrophagesSubsequent development of pulmonary fibrosis and severe anemia**Causes and associated conditions** Idiopathic pulmonary hemosiderosis (IPH)Secondary pulmonary hemosiderosisCardiovascular:Congestive heart failurePulmonary hypertensionMitral valve stenosisInflammatory/autoimmuneGoodpasture syndromeRheumatoid arthritisWegener granulomatosisHenoch-Schönlein purpuraAllergicHeiner syndrome (cow's milk hypersensitivity)**Clinical presentation** Iron deficiency anemiaHemoptysis (helpful if occurs, but infrequent)Alveolar infiltratePresence of hemosiderin; it takes 48--72 h for macrophages to convert erythrocyte to hemosiderinWidely variable from asymptomatic with infiltrates and anemia to shock and sudden deathAfter episode of hemorrhage , the patient will present with wheezing, cough, dyspnea, bronchospasm, and alteration of blood gases**Diagnosis** Best guided by consulting pulmonologistRecurrent "pneumonia", fever, cough, CXR abnormalitiesHypochromic microcytic anemiaElevation of plasma bilirubinInfiltrates are typically bilateral and may spare the apices, often with hyperaerationIgE, cow's milk antibody levels, stool specimen for hemeUrinalysis for nephritisAntinuclear antibodies (ANA), antineutrophil cytoplasmic antibodies (ANCA), and anti-glomerular basement membrane (GBM)Lung biopsy if diffuse alveolar hemorrhage (DAH)**Management** Corticosteroid is the treatment of choice for IPHTreatment is highly dependent on the underlying cause

Acute Bronchiolitis {#Sec32}
===================

**Background** Viral bronchiolitis is the most common lower respiratory tract infection in those under 2 years of ageRespiratory syncytial virus (RSV) is responsible for more than 50% of acute bronchiolitisOther common causes are human metapneumovirus, parainfluenza, adenovirus, influenza, rhinovirus, and mycoplasma**Risk Factors** Maternal asthmaMaternal smokingPersistent rhinitisEczema at \< 1 year of age**Clinical presentation** Nasal congestion, rhinorrhea, and coughTachypnea or elevated respiratory rate is the earliest and most sensitive vital sign changeNasal flaring , grunting (in infants), and suprasternal, intercostal, and subcostal retractions are evidence of increased respiratory effortNasal suctioning and repositioning may allow for a more accurate assessment of lower respiratory tract involvementCommon: Crackles, wheezing, and referred upper airway sounds upon auscultationApnea may be more prominent than wheezing in infants \< 2 months or former preterm infantsSymptoms can range from mild tachypnea to frank respiratory failureClinical course is expected to worsen, with peak symptoms noted around days 3--4 of illness ("day of illness")"Day of illness" is an important variable for providing anticipatory guidance for outpatient management and in making decisions regarding admission and discharge of patients**Diagnosis** Clinical symptoms lead to diagnosis; subsequent evaluation is important in determining treatmentInitially must assess respiratory rate and oxygen saturation because work of breathing, tachypnea, and hypoxia are most clinically significant in determining severityCXR warranted for infants in respiratory distressCXR commonly demonstrates hyperinflation, patchy atelectasis, and infiltratesIn infants under 30 days old, the risk for serious bacterial infection (SBI) warrants full evaluation for SBI and administration of empiric antibioticsRecognize that infants older than 30 days with bronchiolitis are at a lower risk for SBIs, thus allowing for decreased invasive testing and observation without administering antibiotics to patients who have classic presentations**Management** Mainstay of treatment is supportive: Oxygen for hypoxia, hydration, nasal suctioning, and positioning to elevate chest to 30°When feeding adequately and work of breathing improves, oxygen can be discontinued if saturations are 90--92% for most of the timeInfants with respiratory distress and desaturation or dehydration should be hospitalizedThe American Academy of Pediatrics does NOT recommend the use of bronchodilators or systemic steroids in the routine treatment of bronchiolitisHowever, those with recurrent wheezing may respond to bronchodilator therapyCorticosteroid medications, inhaled or administered systemically, should not be routinely used in the treatment of bronchiolitisIf bronchodilator makes the wheezing worse or increases work of breathing, consider pulmonary consultation for trachea or bronchomalaciaSweat chloride testing for patients with recurrent wheezing and who are resistant to treatment is recommendedRibavirin should not be used routinely in the treatment of bronchiolitis**Prevention** Palivizumab (Synagis®) 15 mg/kg intramuscular (IM) for premature and high-risk infants as monthly IM monoclonal antibody injectionHandwashing is best measure to prevent nosocomial infection

Bronchopulmonary Dysplasia (BPD) {#Sec33}
================================

**Background** Definition has changed since initial description in the 1960s"Old" BPD in late premature infants treated with high peak inspiratory pressures and high oxygen concentrations leading to necrotizing bronchiolitis, pulmonary hypertension, alveolar overinflation, atelectasis, cystic disease, and pulmonary fibrosis"New" BPD definition revised in 2000 after use of CPAP, gentler ventilation, antenatal steroids, and surfactant instituted as standard*Immature lung* resulting in alveolar arrest and dysmorphic pulmonary vasculature; *lung injury* from oxygen therapy, positive-pressure ventilation, infection, inflammation, and fluid overload; and *inadequate lung injury repair* with ongoing inflammationOther risk factors : lower birthweight, gestational age (\< 32 weeks), chorioamnionitis, and *Ureaplasma* colonization**Clinical Presentation** Need for oxygen, which can progress to respiratory failure leading to increased or progressive need for ventilatory supportGrading of "new" BPD based on ongoing need for oxygen in premature infants who required oxygen at 28 daysOn reassessment at 36 weeks postmenstrual age:Mild: On room airModerate: FIO2 \< 30%Severe: FIO2 \> 30% or on positive-pressure ventilationCXR can present with areas of opacification, atelectasis, hyper-expansion, and pulmonary edemaSequelae of BPD and associated conditions include:Tachypnea, retractionsSuboptimal growth, increased caloric requirementsDysphagia and GER can lead to aspirationNeurodevelopmental delays with cerebral palsy being the most common presentationHeart failure secondary to pulmonary hypertension, ventricular hypertrophy, pulmonary overcirculation from right-to-left shunting**Management** Prevention: Good prenatal care, prevention of prematurityPostnatal management leading to reduced incidence of BPD:Use of gentle ventilation , permissive hypercapnia, noninvasive forms of airway pressure/ventilationAssure growth and adequate nutritionVitamin A supplementation in extremely low birthweight infants shown to reduce incidence of BPDScreen for and treat for pulmonary hypertensionUse of systemic steroids postnatally decreases risk of BPD and improves extubation success. However, **routine use is contraindicated** due to increase in long-term risk of neurodevelopmental impairmentManagement once BPD diagnosed:Multidisciplinary follow-up of neurodevelopmental, cardiovascular, and nutritional sequelaeBronchodilators, inhaled steroids, diuretics are frequently usedInsufficient data related to long-term outcomesShort course of steroids for acute exacerbationsPrevent infections ; prophylaxis with palivizumab decreases frequency of RSV-related hospitalizations

Asthma {#Sec34}
======

**Background** Heterogeneous disease characterized by chronic inflammation of the airwaysUS prevalence of childhood asthma ranges from 10% to 15%Wheezing observed in about 3% of infants before 3 years of ageSeveral asthma phenotypes have been described based on onset of symptoms and natural course of the disease process:TransientEarly onset at \< 1 year oldDecreased lung function at birthResolved symptoms by mid-childhoodNo further reductions in pulmonary functionNonatopicEarly onset at \< 3 yearsVariable clinical courseLate onsetOnset \> 3 yearsVariable clinical coursePersistentEarly onset \< 3 yearsAbnormal lung function by 3 yearsMost patients are atopicAsthma symptoms are more common in boys before puberty, but more severe in girls after pubertyThe was developed to help predict which children would be likely to develop persistent asthma symptomsIts negative predictive value is better than its positive predictive valuePositive if:1 or more major risk factors: Parental history of asthma, atopic dermatitis, sensitization to aeroallergen*OR*2 or more minor risk factors: Sensitization to food, more than 4% eosinophilia, wheezing apart from upper respiratory tract infections**Pathophysiology** Inflammation plays a key role in asthma pathophysiologyImportant contributors to the inflammatory response include:Cell types including lymphocytes, eosinophils, mast cells, neutrophils, macrophages, smooth muscle cells, and epithelial cellsInflammatory mediators such as IL-5, IL-4, and IL-13IgE plays an important role in activation and maintenance of allergic diseaseEarly-phase reaction or Type I IgE-mediated reactions occur within minutes of an allergen-related triggerCells (such as mast cells) release preformed inflammatory mediators that can lead to vasodilation, edema, bronchoconstriction, and increased airway mucus secretionEarly airway obstruction occurs, in addition, there is activation of leukocytes, which in turn leads to late-phase IgE-mediated reactionsA late-phase IgE-mediated reaction follows 2--12 h laterCharacterized by persistent obstruction and mucus hypersecretionThe late reaction is the consequence of inflammatory mediatorsRespiratory infectionsViral respiratory infections are the most common trigger of exacerbations in children (especially those \< 10 years) and have been associated with future development of asthmaBronchiolitis associated with RSV and rhinovirus in early childhood increases risk of developing asthma**Assessment** There is no diagnostic test for asthmaDiagnosis is based on constellation of clinical symptoms including presence of airflow limitation that is at least partially reversibleExclusion of alternative diagnoses (Table [20.2](#Tab2){ref-type="table"})Assess for associated comorbidities, including obesity, GER, rhinitis/sinusitis, depression, anxiety , sleep-disordered breathing, and allergic bronchopulmonary aspergillosis**Typical symptoms:** Wheezing, chest tightness, shortness of breath, coughSymptoms are usually worse at night and early morningThe more symptoms, the more likely the diagnosisIf cough only symptom or chronic sputum production reported, broaden your differential**Common triggers:** Respiratory infections (especially viral infections)ExerciseInhaled allergens (e.g., pollen, pet exposure, dust mites, cockroaches, mold)Irritants (tobacco smoke, air pollution)Medications (e.g., nonsteroidal anti-inflammatory medications, beta-blockers)Changes in weather**Physical findings and objective data:** Wheezing on exam, especially on forced exhalation; signs of atopy such as allergic shiners, rhinitis , or eczemaPFTSpirometry measurements before and after bronchodilator recommended in the assessment of patients ≥ 5 years/oLook for obstruction on spirometryUse bronchodilator response to assess reversibilityDecline in lung function (FEV1 and FEV1/FVC ratio) can usually be seen in those with symptoms starting \< 3 years and is noted by 6 yearsExercise challenge can be used to evaluate for exercise-induced asthmaBaseline spirometry obtained prior to treadmill challengeSpirometry obtained after exercise to document drop in pulmonary functionCXRMay show hyperinflation, peribronchial wall thickening, atelectasisMost helpful to evaluate for differential causes of symptomsAllergy testingSkin testing or serum testing may help in identifying sensitization to inhaled perennial allergens**Asthma classification** Severity is best assessed prior to initial controller therapy (Table [20.3](#Tab3){ref-type="table"})Assess components of severity: impairment and risk**Impairment:** Relates to the frequency and intensity of symptoms, how the disease affects day-to-day function**Risk** estimates likelihood of exacerbations or having reduced lung function Clinical presentation of EIA Shortness of breath, coughing, wheezing, chest tightness, or pain associated with physical activity. Can present in isolation or associated with symptoms of poorly controlled asthmaSymptoms present during or minutes after exertion, peak after 5--10 min of exercise, and improve within 20--30 minUsually self-limited but may result in a severe asthma attackManagement of EIAWarm-up period 15 min prior to exercise and wearing scarf/mask may reduce symptomsIn 80% of patients, short-acting beta-agonists (SABAs) before exercise prevent symptoms for about 2--3 hMontelukast can lead to decrease in bronchospasm in about 50% of patients, but onset of action is several hours after administration**Management of asthma** ***Assessment and monitoring:*** After initial diagnosis: Review response to therapy, reassess severity and control, adjust therapy to reduce impairment and riskPeriodic reassessment recommended due to variable nature of asthmaAnnual increase in asthma exacerbations seen in SeptemberReassess patients every 2--6 weeks initially to gain disease control and then every 1--6 monthsAssess frequency of daytime symptoms, nighttime symptoms, and reliever use over the past monthCan use asthma control tools such as the Asthma Control Test (ACT) or Asthma Control Questionnaire (ACQ) as part of assessmentEvaluate technique and compliance with controller therapyPFT at initial assessment, after treatment and stabilization of symptoms, during periods of uncontrolled symptoms, and at least every 1--2 yearsIncreased risk of exacerbation *if 1 or more*:Uncontrolled asthma symptoms, increased use of SABA, inadequate dose or use of ICS, \< 60% FEV1, psychological and/or socioeconomic barriers, comorbidities, eosinophilia, exposure to known triggers, history of pediatric intensive care unit or intubation, ≥ 1 severe exacerbation in the last yearConsider step-down in therapy if asthma under good control for at least 3 months***Education:*** Self-management education (patient and families) key in individual asthma control and improve outcomesProvide asthma action plan that provides guidance in daily management as well as plan of care for worsening symptoms***Control environmental factors and comorbidities:*** Assess for allergen exposures either by skin testing or serum testing and correlate with medical and exposure historyPatients should reduce exposure to allergens, irritants, and pollution to which they are sensitized or have a reactionAssess for and control comorbidities associated with increased risk for poor control: Obesity, allergic rhinitis/sinusitis, allergic bronchopulmonary aspergillosis, OSA, depression, and other psychosocial factors.***Medications:*** Initial treatment based on severity category (Table [20.4](#Tab4){ref-type="table"})On reassessment of asthma control, adjust therapy regardless of initial severity classification.**Beta-2 agonists** Relieve airway constriction by binding to receptors on airway smooth muscleFrequent use can signal poor asthma controlShort-acting beta-2 agonists (SABA)Onset of action is within 15 min, but of relatively short duration (3--4 h)Long-acting beta-2 agonists (LABA)Effects can last at least 12 hUsed in combination with ICSAdverse effectsAgitation, irritability, tremors, tachycardia, insomnia, arrhythmias; higher doses used during acute asthma exacerbations can lead to hypokalemia or hypoglycemia**Inhaled corticosteroids**Most potent and effective medication for long-term control of asthmaDecrease airway inflammation and bronchial hyperresponsiveness, relieve asthma symptoms, and improve lung functionPatients should rinse and spit out after inhalationAdverse effectsOral thrush, oral absorption, and higher-dose ICS use may lead to decrease in growth velocity and adrenal suppression**Leukotriene receptor antagonists**Block leukotriene, which acts as a potent mediator leading to bronchoconstriction, vascular permeability, and increased mucus production and activates inflammatory cellsUsually an add-on therapy and not preferred treatment option in mild persistent asthmaAdverse effectsGenerally, well tolerated, but associated with upper respiratory tract infection, fever, headache, sore throat , behavior/mood-related changes**Acute asthma exacerbations** Patients present with acute or subacute worsening from baseline symptoms and/or pulmonary functionBrief initial assessment should concentrate on time of onset and possible triggers, severity compared to previous exacerbations, recent use of asthma medications, and associated cardiorespiratory processSevere exacerbation presentation: shortness of breath, inability to speak in full sentences, sitting hunched, agitated, accessory muscle use, tachypnea and tachycardia, pulsus paradoxus \> 20 mmHg, SpO2 \< 92% (after an hour of therapy is a good predictor for hospitalization needs), PEF \< 40% baselineLife-threatening exacerbations can present with silent chest, drowsiness, or confusionCXR not recommended routinely, but patient can present with atelectasis, which needs to be clinically differentiated from pneumoniaTherapy for acute exacerbations:Oxygen as needed to keep SpO2 \> 90%Three SABA treatments spaced every 20--30 minAdding high doses of ipratropium bromide leads to decreased rate of hospitalizationSystemic corticosteroids to patients with moderate to severe exacerbations or with poor initial response to SABA Table 20.2Differential diagnosis for asthmaRed flagsPossible diagnosisSudden onset of symptoms, witnessed choking, localized wheezingForeign body aspirationCoughing and choking when eating or drinkingDysphagia with aspirationSneezing, cough, nasal congestionChronic upper airway cough syndromePoor growth and low BMICystic fibrosis, immunodeficiencyChronic rhinorrhea, recurrent sinusitis, early-onset respiratory symptomsCystic fibrosis, primary ciliary dyskinesiaAcute-onset dyspnea and/or stridor in teensVocal cord dysfunctionChronic wet productive cough, recurrent infectionsBronchiectasisRecurrent pneumoniaImmunodeficiency, anatomical abnormalityChronic wet cough, difficulties feeding, early onset, noisy breathingVascular ring, tracheoesophageal fistula, tracheomalaciaHeart murmur, poor weight gain, cyanosis with feedingsCongenital heart diseasePrematurity, prolonged mechanical ventilation or supplemental oxygenBronchopulmonary dysplasia Table 20.3Asthma classificationSeverityDaytime symptoms/SABA useActivity limitationNighttime symptomsPulmonary function***Intermittent***0--4 years≤ 2 days/weekNone0 nights/month5--11 years≤ 2 days/weekNone≤ 2 nights/monthFEV1 \> 80%; FEV1/FVC \> 85%12--19 years≤ 2 days/weekNone≤ 2 nights/monthFEV1 \> 80%; FEV1/FVC \> 85%***Mild persistent***0--4 years3--6 days/weekMinor limitation1--2 nights/month5--11 years3--6 days/weekMinor limitation3--4 nights/monthFEV1 \> 80%; FEV1/FVC \> 80%12--19 years3--6 days/weekMinor limitation3--4 nights/monthFEV1 \> 80%; FEV1/FVC \> 85%***Moderate persistent***0--4 yearsDailySome limitation3--4 nights/month5--11 yearsDailySome limitation\> 1 night/weekFEV1 60--80%; FEV1/FVC 75--80%12--19 yearsDailySome limitation\> 1 night/weekFEV1 60--80%; FEV1/FVC 80--85%***Severe persistent***0--4 yearsDailyExtremely limited\> 1 night/week5--11 yearsThroughout the dayExtremely limitedOftenFEV1 \< 60%; FEV1/FVC \< 75%12--19 yearsThroughout the dayExtremely limitedOftenFEV1 \< 60%; FEV1/FVC \< 80%*SABA* short-acting beta-2 agonist, *FEV1* forced expiration volume in 1 s, *FVC* forced vital capacity Table 20.4Asthma: Initial controller therapy≥ 6 yearsPreferred initial therapy≤ 5 yearsPreferred initial therapyIntermittent asthma symptoms**Step 1**Infrequent viral wheezing and no symptoms in between episodes**Step 1**SABA as neededSABA as neededConsider intermittent ICSPersistent symptoms or high-risk factor for exacerbations**Step 2**Uncontrolled asthma symptoms, \> 3 exacerbations/y or consider trial in those with frequent wheezing (every 6--8 weeks)**Step 2**Low-dose ICSDaily low-dose ICSAsthma symptoms/SABA use \> 2X/week**Step 2**Uncontrolled asthma on low-dose ICS**Step 3**Low-dose ICSDouble low-dose ICSConsider LRTAAsthma symptoms most days or waking \> 1X/week**Step 3**Uncontrolled asthma on double low dose**Step 4**Medium-/high-dose ICS or if ≥ 12 years, low-dose ICS/LABARefer to specialistAdd LTRAAdd intermittent ICS or increased ICS frequencySevere initial presentation (uncontrolled asthma or acute exacerbation)**Step 4**Short OCS course ANDHigh-dose ICS or if ≥ 12 years, moderate dose ICS/LABAUncontrolled asthma after initial therapyStep up therapy or use adjunct therapies**Step 3**: Can add LTRA to low-dose ICS**Step 4**: Can add ipratropium (if \> 12 years) to ICS or add LTRA to high-dose ICS**Step 5**: Refer to specialist for add-on therapy (e.g., tiotropium, anti-IgE, anti-IL-5, low-dose OCS)Adapted with modifications from Global Initiative for Asthma Report \[[@CR1]\]*SABA* short-acting beta-2 agonist, *ICS* inhaled corticosteroid, *LRTA* leukotriene receptor antagonist, *LABA* long-acting beta-2 agonist, *OCS* oral corticosteroid

Pneumonia {#Sec35}
=========

**Background** Lower respiratory tract infection with fever and respiratory symptoms with parenchymal involvement on exam or by CXR findings*Streptococcus pneumoniae* is the most common bacterial cause in children older than 1 week of ageViruses account for 14--35% of casesComplicated pneumonia with empyema and necrosisCommunity-associated methicillin-resistant *Staphylococcus aureus***Most common causes of pneumonia by age group** Neonates (0--3 m)Group B strep and Gram-negative bacteriaEarly and late onsetEarly onset---first 3 days of life with respiratory distressThree weeks to 3 monthsChlamydia trachomatisInterstitial infiltrate on CXRRSV and parainfluenzaBronchiolitis or pneumonia*Streptococcus pneumoniae*Major cause of pneumonia through childhoodBordetella pertussisTracheobronchitis with severe paroxysm, usually no feverThree months to 5 yearsMost common etiology---viruses (RSV, parainfluenza, human metapneumovirus, influenza, and rhinovirus)Strep pneumonia---most treatable pathogenMycoplasma pneumoniaeIncreased incidence in children approaching school ageFive years to adolescenceMost common causeAtypical organisms such as *Mycoplasma* and *Chlamydophila pneumoniaeMycoplasma*---leading cause of pneumonia in school-age children and young adults**Most common causes of pneumonia by geographic location** HistoplasmosisOhio and Mississippi River Valleys and CaribbeanCoccidioidomycosisCalifornia, Arizona , and New MexicoBlastomycosisOhio, Mississippi River Valleys; Great Lakes states*Legionella* Infected water worldwideAvian influenzaSoutheast Asia**Pneumonia via animal vectors** TularemiaRabbits and ticksPsittacosisBirds and parakeetsQ feverSheep, cows, and goats**Pneumonia with associated exanthems** VaricellaHuman to human airborne dropletsMeaslesHuman to human droplets**Clinical presentation** Nonspecific signs and symptomsCough and fever---hallmark symptomsTachypnea is the most sensitive and specific sign of pneumoniaMost children with cough and fever do not have pneumoniaTachypnea, retractions, wheezing, nasal flaring, grunting, apnea, and abdominal pain may be presenting or associated symptomsGrunting may be a sign of impending respiratory failure in younger patients/infantsFindings on exam may be dullness to percussion, crackles, decreased breath sounds, and bronchial breathsIn the absence of fever, tachypnea, increased work of breathing, or auscultatory abnormalities, bacterial pneumonia is unlikely**Diagnosis** Clinical diagnosis as aboveRapid influenza test may help to identify the cause of fever and to reduce unnecessary use of antibioticsCBC, chemistry, or serology will not help in identifying etiology or aid in managementBlood culture rarely helpful (only 10% of the time organism is recovered)ESR and C-reactive protein (CRP) may be elevated but are not specificTuberculin test if there are TB risk factors or TB is being consideredCXR (Fig. [20.3](#Fig3){ref-type="fig"}**)**A CXR will not change clinical management for patients being treated as outpatientAfebrile children do not need a CXRCXR always lags behind clinical response. No need to obtain to confirm response to antibioticsObtain a CXR if:Complicated pneumonia is being consideredClinical deteriorationProlonged fever with no obvious source of infectionAbdominal pain with normal appendix**Management** National guideline for antibiotic initiation with community-acquired pneumonia:High-dose amoxicillin (80--90 mg/kg/day) for uncomplicated cases being treated as outpatientAugmentin or cefuroxime as outpatient, if resistantSchool age or \> 5 years of age azithromycin to cover for *Mycoplasma*Indication for hospitalization: Suspected sepsis, severe dehydration, toxic appearance, hypoxemia (SpO2 \< 90%), unresponsive to outpatient therapy, inability to drinkIntravenous fluids and O2, if needed , and antibioticsConsider blood culture, CXR, chemistry profiles, and CBCIf inpatient: Cefuroxime, ceftriaxone , or cefotaxime are the antibiotics of choiceAdolescents: Fluoroquinolones (levofloxacin, gatifloxacin, moxifloxacin) may be used for atypical pneumoniaIf *Staphylococcus* is considered , add clindamycin or vancomycinUncomplicated pneumonia responds to antibiotics in 48--96 hIf no response or persistent pneumoniaRepeat CXRConsider empyema, bacterial resistance, and nonbacterial pneumonia (FB, CF, pulmonary sequestration, bronchiolitis obliterans, aspiration, and hypersensitivity pneumonitis) Fig. 20.3A 9-year-old female presents with cough and fever. Chest radiograph shows right upper lobe infiltrate.

Bronchiectasis {#Sec36}
==============

**Background** Destruction of the airway wall (bronchi and bronchioles) leads to loss of integrity of the muscular and elastic layers of the bronchial wall, results leading to dilated and collapsible airway**Clinical presentation** Productive cough is most common symptomDyspnea, rhinosinusitis, and hemoptysis are less commonCrackles, wheezing, and rhonchi are often heard; digital clubbing may be present**Differential diagnosis** CF is the most common cause of bronchiectasis in pediatric patients in the USA.Impaired mucociliary clearance (CF and ciliary dyskinesia)Infections (*Mycobacterium tuberculosis*, *Pseudomonas*, adenovirus)Immunodeficiency syndromesImmune-mediated (connective tissue diseases), allergic bronchopulmonary aspergillosis (ABPA), inflammatory bowel disease (IBD)Airway injury (chronic aspiration, inhalation of toxic fumes, hot gases)Congenital or connective tissue abnormalities (yellow nail, Marfan syndrome, alpha-1 antitrypsin deficiency, airway cartilage deficiency, tracheobronchomegaly, Young syndrome)Obstructed airways (retained FB, intraluminal masses, extraluminal compression)**Evaluation** PFT may show obstruction, restriction, or both, depending on etiology and severityCXR may reveal airway dilation, increased pulmonary markings with "tram tracking" (thickening of the bronchial walls), and areas of atelectasisHigh-resolution CT scan is the gold standard and reveals detailed anatomy of the bronchial treeThere is a lack of airway tapering with luminal dilation, bronchial wall thickening, honeycombing, and mucous plugging**Management and prognosis** Determining the primary cause is of critical importance and is best done with direction from pediatric pulmonologistEvaluation may include swallow study, sweat chloride testing, and bronchoscopyMucus clearance should be enhanced with hypertonic saline nebulization, inhaled mucolytics, and chest physiotherapyICS can reduce airflow obstructionChronic macrolide therapy has been found to be as beneficial as anti-inflammatory drugsCulture should be obtainedAggressive treatment of *Pseudomonas* and *Staphylococcal* infections is indicated, but antimicrobial therapy should be targeted to specific pathogensIf bronchiectasis is localized and severe, lobectomy is a last resort in cases without systemic etiology

Cystic Fibrosis {#Sec37}
===============

**Background** Autosomal recessive inheritance pattern due to a mutation on the long arm of chromosome 7Highest incidence in Caucasians, highly prevalent in Latinos and African Americans. Less frequently seen in Asians and Native AmericansCF transmembrane regulator (CFTR) dysfunction/absence leads to:Excessive reabsorption of sodium and deficient chloride secretionPassive movement of water is decreased, and airway secretions are dehydrated with very low surface liquid layerCilia become compressed, inhibiting ciliary clearance and cough clearanceBacteria thrive, and the immune function at the airway surface is also abnormalRepeated bacterial infection leads to airway damage and bronchiectasis in the lungCFTR dysfunction leads to dysfunction in other organ systems:Organ systems primarily involved: respiratory, GI, genitourinary, and integumentary (sweat glands)There are \> 1700 mutations in the CFTR proteinDifferent classes of mutations result in different levels of CFTR function/production, thus variable clinical presentationThe most prevalent mutation is F508 deletion (F508del), associated with both pulmonary disease and pancreatic insufficiency85% of the US population have one copy**Clinical presentation*Pulmonary manifestations*** Cough is most common and consistent symptom. Often productive but can also be dryIncreased anteroposterior (AP) diameter of the chest due to hyperinflation associated with airway obstructionHyperresonance, diffuse or localized cracklesNasal obstruction , nasal polyps, recurrent sinusitisClubbingIn advanced disease: Cyanosis, exercise intolerance, shortness of breath, growth failure, respiratory failure, and deathCommon bacterial pathogens include *Staphylococcus aureus and Pseudomonas aeruginosa*Multidrug-resistant organisms are becoming more common (MRSA*, Stenotrophomonas maltophilia, and Burkholderia cepacia* complex).***Gastrointestinal manifestations*** *Meconium ileus* is seen in up to 20% of newborns with CFCharacterized by abdominal distention, emesis, and failure to pass meconium in the first 24--48 hAbdominal radiograph (KUB) shows air fluid level with ground glass-appearing material in the central abdomenGastrografin enema diagnostic and therapeuticCan give hyperosmolar contrast as wellMay need to consider surgery if medical management fails**Pancreatic-insufficient** (PI) patients will progress to complete or almost complete disruption of pancreatic acini and replacement with fibrous tissue. Lack of endogenous digestive enzymes causes fat malabsorptionSymptoms: Frequent, loose, foul smelling, and greasy stools, flatus, and poor weight gainPI also associated with fat-soluble vitamins (ADEK) deficiencyDeficiencies can cause night blindness, decreased bone density, and neurologic dysfunction (neuropathy, dementia)***Genitourinary manifestations*** Pubertal development is often delayed, particularly if nutrition is poorFemales have decreased fertility related to thick cervical mucusMany females with CF carry pregnancies to term, without detriment to lung function\> 95% of males are infertile due to absence or atretic vas deferens***Integumentary manifestations*** Excessive salt loss in sweat predisposes children to hyponatremia, particularly when hot or exercisingHypochloremic alkalosis and dehydration, especially in hot environments, can be deadly in infants **Complications*Distal intestinal obstruction syndrome (DIOS)*** More commonly seen with poor enzyme adherence, also in those with a history of meconium ileusFecal material accumulates in the terminal portion of the ileum and cecumOsmotic agents such as polyethylene glycol (MiraLAX®) are helpfulCan also give enemas and other stool softeners as an adjunctIf severe or complete obstruction , can require Gastrografin enema to relieve obstruction***Rectal prolapse*** Due to combination of intestinal disease and poor supporting musculature from poor nutritionEvidence of recurrent rectal prolapse in otherwise healthy children is an indication for sweat chloride testing to assess for CF***Nasal polyps*** Most prevalent in teens and young adultsLocal steroids and nasal rinses can be of benefit for symptom controlIf there are nasal obstructive symptoms such as chronic rhinorrhea, snoring, and sinus pain or pressure, surgical intervention is warrantedEven with surgical resection , polyps are likely to return***CF-related liver disease*** Found in 2--3% of casesMore common in those with severe mutations with little CFTR functionMainstay of treatment is to prevent ongoing liver damage and associated complications of portal hypertension and cirrhosis***CF-related diabetes*** Most common comorbidityAffects 20% of adolescents and up to 40% of adultsShares features of both Type I and Type II diabetes but is a distinct entityPrimarily caused by insulin insufficiency, but fluctuating insulin levels also play a partOften clinically silent , screen with oral glucose tolerance test (OGTT) annually after age 10 years **Diagnosis** ***Newborn screening:*** US states use different methods of testingIn most states , initial testing uses immunoreactive trypsinogen testing and, if elevated, limited DNA testingConfirmatory sweat testing is recommendedNewborn screening can miss positive cases, especially pancreatic sufficient or those with less common mutations. CF must be a consideration if there are clinical features***Sweat chloride*** is abnormal if \> 40 in infant less than 6 months, and \> 60 in those older than 6 monthsPilocarpine iontophoresis is used to stimulate sweatingPositive results should be confirmed with genetic testingNegative results with high clinical suspicion should also have genetic testingFalse-positive sweat chloride can occur:If testing is completed on skin affected by eczema or contaminated with lotionHypothyroidismSkin disordersUntreated adrenal insufficiencyNephrogenic diabetes insipidusHypoparathyroidismSevere malnutrition***DNA testing*** can confirm and, when sequencing is sent, will identify \> 95%***Pancreatic function testing*** Pancreatic fecal elastase preferredCan assess fecal fat but much less accurate**Management per CF Foundation Guidelines** ***Centers of care:*** Care is managed in a network of multidisciplinary centers.***Visits:*** Infants seen monthly for follow-up until age 1 and then quarterly***Imaging:*** CXR done annually , generally demonstrating mucous plugging and central and upper lobe bronchiectasisMay need CXR to evaluate more closely for bronchiectasis***PFT*** via spirometry assessed quarterly starting at age 5 yearsInitially obstructive process , and then with increasing lung damage, a restrictive process is noted***Microbiology*** Sputum cultures to be assessed a minimum 3 times per yearFirst common bacteria noted is *Staphylococcus aureusPseudomonas* is next commonly seen and treated to eradicate due to potential for colonization and hastening lung damageAlso, commonly seen: MRSA, *Stenotrophomonas maltophilia*Low prevalence but primarily seen in CF: *Burkholderia cepacia***Primary goals of management** Maintain lung function as close to normal as possible.Mainstay therapies include *hydration of airway surface layer* with hypertonic saline, *liquefying mucus* with use of dornase alfa, and *clearance of airways* using various ACTsPrevent infections by limiting exposure to other CF patients and other reservoirs of infection (freshwater lakes, humidifiers, hot tubs)Treat infections when present with directed antimicrobial therapyEnsure adequate nutrition through high-calorie diet, appropriate enzyme supplementation, and close monitoring of growth**Managing** Mild acute exacerbation treatmentIncreased inhaled bronchodilator therapies and mucolyticsIncreased ACTsUsually oral antimicrobialsModerate and severe pulmonary exacerbationsUsually require hospital admission for IV antibioticsAggressive respiratory therapiesMay require additional nutritional intervention to maintain adequate growth during illness**Standard therapies for treatment in CF** Pancreatic enzyme replacement orallyMultivitamins (particularly fat-soluble vitamins)BronchodilatorsHydrating agents (7% hypertonic saline)Mucolytics (dornase alfa)Antibiotics (inhaled, oral, or IV)ACT/chest physiotherapy (CPT)Oscillating chest compression vestPEP (positive expiratory pressure) devicesAutogenic drainageDirected coughing, huff coughingAnti-inflammatory agentsAzithromycinInsulin for CF-related diabetesCFTR modulator drugs to improve ion transportIvacaftor; ivacaftor/lumacaftor; ivacaftor/tezacaftorLung transplant indicated for severe and end-stage lung diseaseSurgical intervention requiredMeconium ileusIntussusceptionGastrostomy tube placementRectal prolapse**CF care across the life span** Transition to adult care is a requirement of all accredited CF centersThere is often formal preparation for patients 18--21 transitioning to adult careMedian survival is currently 37 yearsInfants now born with CF and who are cared for in an accredited CF center will likely survive beyond age 50

Primary Ciliary Dyskinesia {#Sec38}
==========================

**Background** Autosomal recessive disorder with extensive genetic heterogeneityCharacterized by dysmotile , immotile, or absent ciliaThe ciliary defects lead to abnormal mucociliary clearance**Clinical presentation** Symptoms in organs where ciliary motility is important for normal functionNeonatal respiratory distress or neonatal pneumonia (frequently misdiagnosed as transient tachypnea)Recurrent pneumonias and bronchiectasisRecurrent wheezing frequently diagnosed as asthmaChronic persistent rhinosinusitisNasal polyps and recurrent otitis media; recurrent otitis media may begin in neonatesMen are infertile and women have decreased fertility**Diagnostic evaluation** Gold standard: Cilia from nose or trachea by brushings or mucosal biopsy for evaluation of ciliary abnormalities on electron microscopy (absent, abnormal dynein arms, radial spokes, doublet arrangements)Genetic testing---need two mutations in a single gene for diagnosis. Problematic due to heterogeneity, and inability to identify two mutations does not rule out diagnosisCT scanSinuses: Paranasal sinuses involvementChest: Bronchiectasis**Management** ACT, antibiotics for infections documented on culture with sensitivities, ENT evaluation for surgery if needed

Extrapulmonary Respiratory Conditions {#Sec39}
=====================================

Pleural Effusion {#Sec40}
----------------

**Background** \> 10 mL fluid in the thoracic cavityDue to excessive filtration or defective absorptionNormal fluid balance0.1--0.2 mL/kg of sterile colorless fluidNinety percent filters from arterial capillaries, reabsorbed at venous capillariesAbout 10% returned via lymphaticNormal pleural fluid (0.3 mL/kg)EtiologiesPneumonia is the most commonNeonatal period: Chylous effusion most commonOthers: Malignancy , renal disease, trauma, congestive heart failure, and systemic diseases**Clinical presentation** Suspect in any child with worsening pneumoniaRespiratory distress , tachypnea, cough, chest pain with pleural inflammationDecreased to absent breath sounds, pleural rub with smaller collection of fluidEgophonyDullness to percussionMidline shift**Diagnosis and management** Transudate: Clear or straw colored; low protein and lactate dehydrogenase (LDH)Exudate: Straw colored or cloudyPleural fluid/serum protein ≥ 0.5Pleural fluid/serum LDH ≥ 0.6Pleural fluid LDH \> 2/3 of the upper limit of normal for serum LDHAppearance:Purulent fluid---infectionThin white milky fluid---chyleBlood---trauma or malignancyCXR---opacification of thorax, blunted costophrenic angles (Fig. [20.4](#Fig4){ref-type="fig"}**)**Decubitus views helpful if fluid is free-flowingUltrasound helpful to evaluate for loculationsCT scan for complicated effusions/empyema to define pulmonary and fluid characteristicsThoracentesisRoutine thoracentesis not recommendedPerform thoracentesis to relieve dyspnea for large effusions, worsening symptoms, sepsis, or a lack of improvement in symptoms despite administration of broad-spectrum antibiotics for diagnostic purposesOxygen for hypoxemiaConsultation with experts as needed Fig. 20.4Chest radiograph of a 2-year-old child with left pleural effusion

Pneumothorax {#Sec41}
------------

**Causes** **Primary spontaneous** Occurs without trauma or underlying causeMore frequently in tall, thin males, likely related to subpleural blebsFamily history is positive in many patientsUsually occurs at rest, but can be precipitated by air travel in an unpressurized cabin, weight lifting, and Valsalva maneuver**Secondary pneumothorax** Related to an underlying lung issue (asthma, CF, necrotizing pneumonia, interstitial lung disease)Trauma (blunt trauma)Loud music (air pressure)Catamenial pneumothorax (unusual condition associated with menses due to passage of intra-abdominal air through a diaphragmatic defect)**Clinical presentation** Onset is abrupt, and the severity depends on degree of lung collapseIn simple pneumothorax, the lung collapses up to 30%In a tension pneumothorax , patient will be hypoxemic, dyspneic, and possibly cyanoticPoint of maximal impulse shifts due to displacement of intrathoracic organs to the opposite side**Diagnosis** CXRUpright, if possibleExpiratory films accentuate the contrast between lung markings and the clear area of the pneumothoraxRecurrence rate is high after primary spontaneous pneumothorax**Management** Small pneumothorax \< 5% may resolve spontaneouslyIf \> 5% of pneumothorax or collapse, or if recurrent or under tension, a chest tube for drainage is necessaryPneumothoraces complicating CF frequently recur, and definitive treatment may be justified with the first episodeOne means of definitive therapy is sclerosing with doxycycline (chemical pleurodesis)Video-assisted thoracic surgery is preferred therapy for blebectomy, pleural stripping, pleural brushing, and instillation of sclerosing agents over open thoracotomyExtensive pleural adhesion and aggressive pleural stripping may interfere with lung transplant potential in the future , an issue that must be discussed with the family

Pneumomediastinum {#Sec42}
-----------------

**Background** Can be traumatic or spontaneousSpontaneous pneumomediastinum occurs when air leaks through small alveolar rupture to the surrounding bronchovascular sheathLess commonly, occurs with air escaping from the upper respiratory tract, intrathoracic airways, or esophageal ruptureTriggers: (Most common) asthma exacerbation and lower respiratory infection; (less common) Valsalva/strenuous lifting and vomiting**Clinical presentation** Chest pain, dyspnea, cough , neck pain, dysphagia, odynophagia**Management** Usually resolves by itself

Thoracic Deformities {#Sec43}
====================

**Background** Thoracic deformities affect rib cage, spine, and respiratory musclesAbnormalities can result in restrictive disease due to reduced compliance of chest wall and increased workload/fatigue of respiratory muscles

Pectus Excavatum (Funnel Chest) (Fig. [20.5](#Fig5){ref-type="fig"}) {#Sec44}
--------------------------------------------------------------------

**Background** 1/400 births, more common in males, rare in African AmericansCan be isolated, familial, or associated with connective tissue diseases (e.g., Marfan or Ehlers-Danlos syndrome), neuromuscular disease (e.g., spinal muscular atrophy)Incidence: \> 90% of congenital wall anomalies**Clinical presentation** Often noted at birth, may be not associated with any symptomsRange from asymptomatic to increasing symptoms in more severe casesExercise intoleranceFatigueChest painPalpitationsRecurrent chest infectionsWheezingStridorCoughTall and thinChildren may experience significant psychological stress because of cosmetic appearance**Evaluation** CXR; increased AP diameterCT for Haller index (HI) ; if significant, should be repairedHI = lateral internal rib cage dimension/AP internal sternum to vertebrae dimensionNormal value HI: 2.5Surgical repair if HI \> 3.25 and/or cardiopulmonary involvementECG commonly abnormal ; right axis deviationEcho may demonstrate cardiac compression and mitral valve prolapse**Management** Based on severity of deformity and physiologic compromiseMild: Observation and physical therapy to maintain postureCorrective surgery if significant physiologic compromise (Nuss or Ravitch procedure) Fig. 20.5Pectus excavatum. A 12-year-old healthy boy with funnel-shaped chest

Pectus Carinatum (Pigeon Chest) {#Sec45}
-------------------------------

**Background** Anterior displacement of midsternum and adjacent costal cartilageRare: 1/1500 of chest wall deformitiesAssociated with mild to moderate scoliosis, mitral valve prolapse, and coarctation of aorta**Clinical presentation** Rarely causes limitationsPhysical appearance most common complaintHI less than two is significant**Management** Surgery for cosmetic and psychological stress

Scoliosis {#Sec46}
---------

**Background** Cobb angle = angle from most tilted vertebrae above and below the apex of the curveScoliosis defined as lateral curvature of the spine with Cobb angle \> 10°Curvatures \> 50° more likely to be progressiveExtreme curvatures can lead to respiratory compromise due to restrictive chest wall disease**Management** Observe for progressionBracingSpinal fusion for curves \> 40°--45°

Pulmonary Hypertension {#Sec47}
======================

**Background** Mean pulmonary artery pressure of 25 mm Hg or more at restCan be caused by left heart disease, lung disease (including BPD), thromboembolic disease, autoimmune disease , variety of other disease or idiopathic**Clinical presentation** Exertional dyspnea, progressive fatigue in older childInfants less specific: Poor appetite , failure to thrive, diaphoresis, tachypnea, tachycardia, and irritabilitySyncope, presyncope, and chest pain are features of more advanced disease; hemoptysis late and sometimes fatal symptom**Management** Outcome in pediatrics has improvedShould be seen by specialist (cardiology or pulmonology)Patients may require a combination of therapies, and some patients require surgery (septostomy)**Cor pulmonale** Right ventricular (RV) hypertrophy leading to RV failure caused by increased afterload caused by pulmonary hypertensionCan be caused by chronic lung disease, bronchopulmonary dysplasia, cystic fibrosis, arterial hypertension, neuromuscular disease

Obstructive Sleep Apnea (OSA) {#Sec48}
=============================

**Background** OSA and primary snoring are part of a spectrum of sleep-disordered breathing**Primary snoring** = Incidence 12--20%; no discrete obstructive events or gas exchange abnormalities**OSA** = Prevalence 2--4% in healthy children; obstructive apnea and hypopneas often seen with arousals, disturbed sleep, and gas exchange abnormalitiesThe disorder can occur at any age but is most common in the preschool age group (2--6 years) and adolescentsA higher prevalence has been reported in African American and obese children**Risk factors and associated conditions** Adenotonsillar hypertrophyObesityCraniofacial abnormalities (such as midface hypoplasia and micrognathia)Hypotonia (e.g., Down syndrome)Neuromuscular diseaseCerebral palsy**Clinical presentation** All children should be screened for snoringSigns and symptoms that may signal OSASnoringGasping during sleepEnuresis (especially if secondary)Restless sleeperUnusual positioning during sleep (hyperextended neck, sleeping propped up)CyanosisSweating during sleepMorning headachesDaytime sleepiness in older childrenADHD-like symptoms , including hyperactivity and/or inattention, difficulty concentratingAdenoidal facies as well as signs of atopy or nasal congestionChronic mouth breathing with chronic nasal congestionTonsillar hypertrophyObesityFailure to thriveUnexplained hypertension**Management** History and physical exam cannot distinguish between primary snoring and OSAPolysomnography diagnostic test of choiceComplex, high-risk patients (e.g., craniofacial disorders, genetic syndromes, neuromuscular disorders , severe OSA) should be referred to specialistPatients with neuromuscular disease may desaturate during sleep but appear well awakeOvernight saturation monitoring may be a helpful screening tool for sleep-disordered breathing in these patientsAdenotonsillectomy is first-line therapy and curative in about 80% of children with OSANoninvasive positive airway pressure is an option for poor surgical candidates or those with residual OSA after surgeryHigh-risk patients should be monitored as in-patients postoperativelyPatients should be re-evaluated postoperative to determine if additional treatment is required

Acute Life-Threatening Event (ALTE)/Brief Resolved Unexplained Event (BRUE) {#Sec49}
===========================================================================

**Background** Common associations with ALTEGER disorder most common association for awake ALTEPrevalence of GER in infants with ALTE as high as 70%Highly symptomatic infants may benefit from therapy with antacids, positional changes, and thickened feedingsNeurologicSeizures second most common associationHigh index of suspicion of child abuse importantUp to 10% presenting ALTE associated with child abuseViral respiratory infectionsRSV most commonly associated ALTEMore common in \< 2 months, lower birthweight, history of prematurityBRUE now preferred term to more subjective ALTE, but terms frequently used interchangeablyBRUE\< 1 year of ageSudden, brief, and resolved episode with ≥ 1 of the following:Cyanosis or pallorAbsent, decreased, or irregular breathingChange in toneAltered responsivenessUnexplained after adequate history and physicalPresence of BRUE does not predict SIDS**Management** Low-risk BRUE: Patients \> 2 months, older preterm infant (\> 32 weeks and postconceptual age \> 45 weeks), event \< 1 min, no previous events, no need CPR, negative history and examManagement of low-risk BRUENo need for admissionWorkup considered even in low-risk BRUEPertussis testing as infants may present with few symptomsPulse oximetry monitoring in the emergency departmentECG due to severe outcome associated with channelopathiesHas good negative predictive valueObservation, further testing , and treatment as supported by history and exam

Sudden Infant Death Syndrome (SIDS) {#Sec50}
===================================

Factors associated with triple risk model of SIDS:Critical period in developmentRisk peaks at 2--4 months with most deaths having occurred by 6 monthsMale predominanceInfant vulnerabilityBrain stem dysfunctionGenetic predispositionDefects in arousalPrematurity, low birthweightPoor prenatal careEnvironmental factorsProne sleep positionTobacco smoke exposureSoft beddingCo-sleepingOverheatingYoung maternal ageIncreased risk in siblings, but risk of second child death \< 1%National recommendation on SIDS prevention"Back to sleep ": Supine position. "Tummy to play": Awake and monitoredMarked decline in SIDS rate following mass education of this public policyFirm mattressCool ambient airNo soft object or loose beddingNo co-sleepingEncourage breastfeedingNo smokingSleep in parents ' room for 1st year, but on separate surfacesPacifiersUse pacifier once breastfeeding has been establishedOffer pacifier at bedtime or nap time

Pearls and Pitfalls {#Sec51}
===================

**Diagnostic Testing for Respiratory ConditionsInterpretation of spirometry** Obstruction: N ↓ FVC, ↓ FEV1, ↓ FEV1/FVC, ↓ FEF 25--75Restriction: ↓ FVC, ↓ FEV1, N FEV1/FVC, ↓ FEF 25--75**Blood gas analysis** Arterial blood gas analysis (see Table [20.1](#Tab1){ref-type="table"})In capillary blood gases, values are comparable to arterial pH and pCO2, but pO2 measurement in CBG is less reliable.**Chest imaging** Imaging in suspected FB:Get inspiratory and expiratory or bilateral decubitus views. May be able to see asymmetric hyperinflation in side with foreign body.Most foreign bodies are not seen, as they are radiolucent. **General Signs and SymptomsStridor/wheezing** **In**spiratory---**Ex**trathoracic swelling or obstruction will lead to airway collapse on inspiration. Example: Laryngomalacia**Ex**piratory---**In**trathoracic swelling or obstruction will lead to airway collapse on expiration. Example: Tracheomalacia**Biphasic stridor---indicates fixed airflow obstruction---subglottic space obstructionLaryngomalacia:** Most common cause of stridor in infants, accounts for up to 75% of all causes of stridor**Choanal atresia:** Infant/newborn in respiratory distress with inability to pass a 6F catheter into oropharynx through nose**Left vocal cord paralysis:** Associated with trauma to the recurrent laryngeal nerve at birth or surgical trauma**Subglottic hemangioma:** 50% accompanied by cutaneous hemangiomas of head and neck. Inspiratory or biphasic stridor, which worsens as hemangiomas enlarge**Viral croup:** Course of viral croup in infants younger than 1 year of age is prolonged. Symptoms often improve during the day with recurrence of symptoms in the early hours of the morning.**Epiglottitis:** Stridor is not a prominent feature.**Cough** Nocturnal cough is rare in normal childrenAssociations: Brassy (tracheal irritation, tracheomalacia); barky (croup); honking (habit cough); staccato (chlamydia, mycoplasma); paroxysmal/whoop (pertussis, CF, FB)**Exercise intolerance** Vocal cord dysfunction: More common in adolescent females. May mimic EIA*---*need to consider if not responding to EIA treatment**Hemoptysis** Differentiating from hematemesis (vomiting blood) and epistaxis (nasal bleeding) can be tricky.Most common reason for symptom usually not true hemoptysis, but bleeding from upper airway (e.g., nasal bleeding)**Congenital airway and pulmonary malformations** With symptoms and presenting during infancy, most will require surgical intervention.**Acute bronchiolitis** Most common lower respiratory tract infection in \< 2 yearsEtiology: RSV \> 50%Apnea may be more prominent than wheezing in infants \< 2 months or former preterm infants.Peak symptomatology at days 3--4 of illness ("day of illness")"Day of illness": Important variable for providing anticipatory guidance in outpatient management and making decisions regarding admission/dischargeRoutine use of bronchodilators or systemic steroids in management NOT recommended**Asthma** Asthma symptoms are more common in boys before puberty, but more severe in girls after puberty.**Early-phase reaction or Type I IgE-mediated reactions** occur within minutes of an allergen-related trigger.**A late-phase IgE-mediated reaction** follows 2--12 h later.Viral respiratory infections (such as RSV and rhinovirus) have been associated with future development of asthma and are the most common trigger of exacerbations in young children.All that wheezes is not asthma! Think about the differential if diagnosis not clear.If cough is the only symptom or chronic sputum production is reported, broaden your differential.ICS are the most potent and effective medication for long-term control of asthma.EIA: In 80% patients, SABA before exercise prevents symptoms for about 2--3 h.Acute asthma exacerbation: SpO2 \< 92% after an hour of therapy is a good predictor for hospitalization need.**Pneumonia** *Streptococcus pneumoniae* is the most common bacterial cause in children older than 1 week of age.Viruses account for 14--35% of cases.For school-age children needing inpatient therapy: Cefuroxime, ceftriaxone, and cefotaxime are the antibiotics of choice.**Bronchiectasis/cystic fibrosis** CF is the most common cause of bronchiectasis in pediatric patients in the USA.CFTR dysfunction/absence leads to thick secretions, impaired mucociliary clearance, recurrent inflammation, and infection, leading to development of bronchiectasis.All US states have newborn screening, but results are not 100% sensitive.Diagnostic tests include sweat testing and DNA testing.Patients should be managed by a multidisciplinary team at a CF care center.Pneumothorax/pneumomediastinumPneumothorax \> 5% hemithorax will require chest tube drainage, but pneumomediastinum usually resolves spontaneously.**Thoracic cage deformities** Pectus excavatum: \> 90% of congenital wall anomaliesScoliosis: Curvatures \> 50° more likely to be progressive. Extreme curvatures can lead to respiratory compromise due to restrictive chest wall disease.**OSA** Higher prevalence in African Americans and obese childrenPolysomnography diagnostic test of choiceAdenotonsillectomy is first-line therapy and curative in about 80% of children with OSA.**SIDS** Peaks at 2--4 months of age, male predominance"Back to sleep" supine position for sleep led to marked decline in SIDS rate
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